Download presentation
Presentation is loading. Please wait.
Published byRalf Merritt Modified over 9 years ago
1
1 2014 ALS PROTOCOL UPDATE Dr. Daniel J. OlssonSusie Surprenant CNYEMS Regional Medical Director CNYEMS Executive Director
2
2 Overview CNYEMS-Midstate-North Country Collaborative ALS Protocol Update. Thirteen of the ALS protocols have been updated to accommodate the new Advanced EMT level. The following slides contain highlighted sections where the protocols changes and/or additions have occurred. Adult Blood Glucose (hypoglycemia) changed to < 60 mg/dL. Adult Naloxone dose changed to 0.4 mg IV; IM or IN. 0.4 mg IV; IM or IN. “Secondary advanced airway device “ verbiage changed to “alternative rescue airway device”.
3
Acute Coronary Syndrome New Medications for AEMT: –Aspirin –Nitroglycerin Paste –Nitroglycerin Spray –Nitroglycerin Tablet 3
4
4
5
Acute Respiratory Distress Asthma or COPD New Medications for AEMT: –Albuterol Sulfate New Skill: –CPAP 5
6
6
7
Airway Management Adult “secondary advanced airway device “ verbiage changed to “alternative rescue airway device”. Intermediates and AEMTs are only able to utilize alternative rescue airway devices for patients in respiratory or cardiac arrest. Examples of alternative rescue airway devices: –Combitube –King Airway –LMA 7
8
8
9
Allergic Reaction / Anaphylaxis New Medications for AEMT: –Albuterol Sulfate –Epinephrine 1:1,000 9
10
10
11
Alerted Mental Status Adult Blood Glucose (hypoglycemia) changed to < 60 mg/dL. Adult Naloxone dose changed to 0.4 mg IV; IM or IN. 0.4 mg IV; IM or IN. New Medications for AEMT: –Dextrose 50% –Glucagon –Naloxone 11
12
12
13
Asystole and Pulseless Electrical Activity (PEA) New Medications for AEMT: –Epinephrine 1:10,000 13
14
14
15
Poisoning / Overdose Adult Naloxone dose changed to 0.4 mg IV; IM or IN. 0.4 mg IV; IM or IN. New Medications for AEMT: –Naloxone 15
16
16
17
Pulmonary Edema New Medications for AEMT: –Nitroglycerin Paste –Nitroglycerin Spray –Nitroglycerin Tablet New Skill: –CPAP 17
18
18
19
Seizures Adult Blood Glucose (hypoglycemia) changed to < 60 mg/dL New Medications for AEMT: –Dextrose 50% –Glucagon 19
20
20
21
V-Fib / Pulseless V-Tach New Medications for AEMT: –Epinephrine 1:10,000 21
22
22
23
Airway Management - Pediatric “Secondary advanced airway device“ verbiage changed to “alternative rescue airway device”. Patients 16 years and older. Intermediates and AEMTs are only able to utilize alternative rescue airway devices for patients in respiratory or cardiac arrest. 23
24
24
25
Fluid Challenge - Pediatric Fluid Administration: –Normal Saline bolus 25
26
26
27
IV / IO Therapy - Pediatric New Skill for AEMT: –Patients 6 years and older: IV or IO access IV or IO access –Patients < 6 years in cardiac arrest: IV or IO access IV or IO access 27
28
28
29
Review of Protocol Changes Adult Blood Glucose (hypoglycemia) changed to < 60 mg/dL. changed to < 60 mg/dL. Adult Naloxone dose changed to 0.4 mg IV; IM or IN. 0.4 mg IV; IM or IN. “Secondary advanced airway device “ verbiage changed to “alternative rescue airway device”. 29
30
30 New Medications for AEMT Level Aspirin Albuterol Sulfate Dextrose 50% Epinephrine 1:1,000 Epinephrine 1:10,000 Glucagon Naloxone Nitroglycerin Paste Nitroglycerin Spray Nitroglycerin Tablet Fluid Administration Normal Saline bolus
31
31 New Skills for AEMT Level Alternative Rescue Airway Device –Patients 16 years and older CPAP – Adult Patients 6 years and older: – IV or IO access Patients < 6 years in cardiac arrest: – IV or IO access
32
32 Next Steps AEMT providers will complete an on-line 2014 AEMT Protocol Test. In order to continue to practice in the Region, an AEMT provider will need to complete the ALS Protocol Update and pass the on-line Protocol Test. The updated ALS Protocols will go into effective December 8, 2014. into effective December 8, 2014. All currently certified Intermediates must be certified under the new AEMT Standards by June 30, 2015. AEMT Standards by June 30, 2015. All Intermediate Protocols will end on June 30, 2015.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.